Recent Finacing
Recent Raise
NapaJen Pharma is a clinical-stage biotherapeutics company that uses an immune cell-targeted oligonucleotide delivery platform to create immunotherapeutics, including anti-CD40 siRNA candidate NJA-730 in Phase 1.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at NapaJen.
